Lv41
672 积分 2022-02-15 加入
Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma
3天前
已关闭
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study
3天前
已关闭
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
3天前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
26天前
已完结
Rethinking B cells in ulcerative colitis: a CAR T cell opportunity
26天前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
1个月前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
1个月前
已完结
Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory microsatellite stable non-liver metastatic colorectal cancer: A phase I nonrandomized clinical trial
1个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
1个月前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
1个月前
已完结
皖公网安备34019202002308